Conclusion Shuxuening injection was effective for treating acute cerebral infarction, probably by decreasing the CRP and TXB2 levels in plasma.
结论舒血宁注射液治疗急性脑梗死的疗效可能与使急性脑梗死患者血浆CRP和TXB2水平下降有关。
Method Plasma 11-dehydrothromboxane B2(DH-TXB2) and thromboxane B2(TXB2) were detected using ELISA in 38 PIH patients and 20 normal non-pregnant women.
方法采用酶联免疫吸附法（ELISA）检测38例PIH患者血浆11-去氢-血栓烷B2（DH-TXB2），同时测定TXB2，并与正常未孕组比较。
From this trial, it was indicated that acti's reducing thrombosis action was the result of inhibiting aggregation and releasing of platelets through reducing whole blood viscosities and TXB2 level.
认为抗脑血栓注射液的抗血栓作用是通过降低全血粘度和TXB2浓度，从而抑制血小板的聚集和释放反应的结果。
From this trial, it was indicated that acti's reducing thrombosis action was the result of inhibiting aggregation and releasing of platelets through reducing whole blood viscosities and TXB2 level.
认为抗脑血栓注射液的抗血栓作用是通过降低全血粘度和TXB2浓度，从而抑制血小板的聚集和释放反应的结果。
应用推荐